INTRODUCTION
An estimated 222,620 cases of colorectal cancer are diagnosed in the 15 member states of the European Community every year (1), a number that underscores the economic and medical significance of this cancer. The incidence of colonic cancer thereby supersedes rectal cancer by one third. By definition, colonic carcinomas include only tumors that are located more than 16 cm above the anocutaneous line or 12 cm above the dentate line, as measured by a rigid endoscope. All carcinomas located below this level are classed as rectal cancer. This is of particular importance when interpreting studies on adjuvant therapeutic modalities, since they often include all tumors above the pelvic reflection of the peritoneum, and therefore rectal cancer, too.
The vast majority of colon cancers, i.e. about 95 % can be resected. In this article, only surgical treatment carried out in curative intent will be considered, which means that all patients with established distant metastases (20 % to 25 %) and those receiving palliative resections because of local residual tumor (3 %-5 %), are excluded. These will be discussed elsewhere in this issue. Likewise, laparoscopic resections will not be dealt with here in any detail.
CARCINOMA LOCATION
The development of colorectal carcinoma over the last few decades reveals a "right shift" trend, with a decrease in rectal carcinoma and an increase in colonic carcinoma which, in turn, also shows a shift to a more proximal manifestation in the right hemicolon (Table 1) .
POLYPECTOMY AND SEGMENTAL RESECTIONS FOR EARLY CANCER
There is wide agreement that colon cancer with a low risk of lymph node metastases and local recurrence can be treated by endoscopic polypectomy or segmental resection. This applies only to grade G1 and G2 (i.e. 'low grade') pT1 carcinomas with no invasion of lymphatic vessels (pT1 'low risk') following a complete resection (R0). In the Japanese literature, invasion depth into the submucosa is a co-criterion for patient selection (2, 3).
The relevant data for low-risk and high-risk tumors in terms of lymph node metastases are shown in Table 2 . In many cases, the diagnosis of cancer in tumors primarily treated as adenomas is established only when the histopathological report is available. It is generally agreed that if, subsequently, these tumors make a resection necessary, it can be performed via the laparoscope. Table 3 presents data on the treatment and followup of patients with pT1 tumors and low-risk histology. The higher rate of distant metastases and shorter survival in patients receiving more radical treatment may reflect patient selection probably due mainly to tumor size, which has not yet been fully analysed as an additional independent factor for the risk of lymph node metastasis.
LYMPHATIC SPREAD AND EXTENT OF RESECTION
The standard approach to cancer of the colon is radical resection of the tumor-bearing segment of the bowel together with systematic removal of the draining lymphatics en bloc. Only few data are available from systematic studies correlating the site of the colon cancer and lymph node metastases as the basis of the existing guidelines.
UNIDIRECTIONAL AND BIDIRECTIONAL LYMPH FLOW
Lymphogenous seeding of a colonic carcinoma is initially to the pericolic lymph nodes, but at most for a distance of 10 cm, and subsequently along the course of the supplying arteries. In the case of carcinomas of the transverse colon involving either of the flexures, the lymph drainage system may be complex. In particular drainage is along the colonic arcade in both oral and aboral directions, but also, in the region of the right flexure, into the lymph nodes above the head of the pancreas. In the remaining transverse colon, lymph drainage may be to the nodes situated along the vascular arcade of the greater curvature of the stomach, and from the left part to the lower surface of the pancreas (4). This pattern of metastasization needs to be taken into account for the lymph node dissection and the extent of the resection, even when there are no evident lymph node metastases.
A carcinoma located at the right flexure may seed to the lymph nodes along the trunk of the middle colic artery, and along the vessels of the right colon. Since only some 10 % of patients have a right colonic artery, the lymph nodes along the ileocolic artery are further potential lymph drainage pathways, so that in the event of a carcinoma at this site, an extended right hemicolectomy involving anastomosis of the terminal ileum to the colon in the region of the left flexure is required.
The extent of the resection as recommended in various European guidelines for the treatment of cancer of the colon is determined by the possible lymph drainage pathways (5, 6, 7). Owing to a lack of investigations and publications meeting EBM requirements these guidelines have hitherto not been based on a higher level of scientific data. However, they are supported by the optimized therapeutic outcome, and the underlying strategies accomplishing this.
Ongoing sentinel node studies in cancer of the colon may substantiate the previous rationale for the extent of the resection based largely on the pattern of established lymphatic spread (8, 9, 10) .
In the individual case, the exact extent of the resection, in particular in the case of carcinomas involving the transverse or descending colon, depends on the relationship of the tumor site to the vascular supply and the size of the lesion.
In some 10 % of carcinomas of the colon, tumor conglomerates involving neighbouring organs may be found. Histologically demonstrable infiltration, however, is seen in only about 50 % of these cases, with the remainder being caused by adhesions due to inflammatory processes. Nevertheless, in both instances, multivisceral en bloc resection to remove all the structures involved is required, the aim being to achieve an R0 resection, while taking due account of the lymph drainage pathways. If the organs involved were first separated -in order for example in the case of a carcinoma located at the right flexure with involvement of the pancreatic head to obtain histological confirmation of true infiltration before performing the partial duodenopancreatectomy thus necessitated -the risk of locoregional recurrence or peritoneal carcinomatosis due to seeding into the abdominal cavity would be at least doubled (11) .
Inconsistent compliance with the guidelines is presumably the reason for the differences still seen in the reported outcomes of surgery.
RADICAL SURGICAL TREATMENT
Radical surgery comprises removal of the tumorbearing segment of the intestine together with the regional lymph node stations, with the latter determining the extent of the resection. In stage IV disease, too, local resection of the primary in compliance with local radicalness criteria to avoid locoregional occurrence should be the guiding principle, since patients undergoing palliative treatment because of distant metastases today may survive for five years and more, which means that local recurrences due to compromised radicalness of the primary intervention, may represent a significant problem later on.
INTRAOPERATIVE STAGING
With regard to the operative procedure in the case of elective surgery, a knowledge of the intra-operative staging does not usually impact on the strategy previously established on the basis of the endoscopic and diagnostic imaging findings. Since the extent of the surgery on the primary tumor usually remains unchanged even in the presence of distant metastases, the intra-operative detection of liver metastasis has no influence on the further procedure. Various studies (12) have established that careful bimanual palpation of the liver and intra-operative ultrasound are equally as effective as pre-operative imaging. Although, with regard to the interpretation of such studies, it must be noted that the technology used is not always described in detail, and may not always be based on a comparison of the most modern equipment available. In our own department, staging of the liver and distant lymph node metastases is done exclusively pre-operatively using ultrasonography and spiral CT, supplemented by an intra-operative search for subserosal liver metastases measuring less than 5 mm in diameter, as also peritoneal metastases.
No value is attached to pre-operative staging of the primary tumor, since, at the present time, neoadjuvant therapy concepts are not being pursued in the case of colonic carcinoma.
The intra-operative cytological examination of fluid from the abdominal cavity for the presence of tumor cells also has no impact on the resection strategy, and it has been shown that, in contrast to tumors of other organic, positive tumor cytology has no impact on the prognosis of colorectal cancer (13, 11) . Currently, in a number of studies, attempts are being made by the individual visualization of the draining lymphatics using radionuclide marking, to establish differentiated lymph node dissection and, oriented to this, individual modifications of radical colonic resections. During this process, in individual cases, unexpected draining lymphatics are sometimes detected. So far, however, this procedure has not found wide acceptance, probably due in the last resort to the fact that general recommendations cannot be derived from this developing examination method.
STANDARD OPERATIONS

CARCINOMA OF THE COECUM AND THE ASCENDING COLON
The standard operation for cancer of the coecum and ascending colon comprises a right hemicolectomy with regional removal of the draining lymphatics of the ileocolic artery and, where present, the right colic artery by central transection of these vessels. Since a separate right colic artery arising directly from the superior mesenteric artery is present in only 10-15 % of the patients, lymphogenous metastasization of carcinomas of the right colon takes place mainly to both the ileocolic artery and the middle colic artery. The trunk of the middle colic artery is preserved, the branches of the middle colic artery running to the right are divided at their origins.
CARCINOMA OF THE RIGHT FLEXURE AND TRANSVERSE COLON
The standard surgical intervention for carcinomas of the right flexure and the proximal transverse colon is extended right hemicolectomy. This involves the additional central ligation of the middle colic artery at its origin in the superior mesenteric artery (Fig. 1) . The distal boundary of the resection is close to the left flexure. The greater omentum with the gastroepiploic ligament and the right gastroepiploic artery and vein corresponding to the tumor is removed. This means that the (distal) gastric antrum including the pylorus or the gastric corpus, is skeletonized along the greater curvature of the stomach, since lymph node metastases over the head of the pancreas or along the gastroepiploic vessels must be expected in about 5 % of tumors at this site. In conjunction with this, the ventral lymph nodes over the head of the pancreas, and also centrally along the trunks of the superior mesenteric artery and vein are dissected free at the lower edge of the pancreas. For this purpose, the right gastroepiploic artery and vein are transected centrally.
CARCINOMA OF THE TRANSVERSE COLON
Tumors located in the middle of the transverse colon and including either of the flexures are treated by resecting the transverse colon and central ligation of the middle colic artery. The greater omentum with the gastroepiploic ligament and the gastroepiploic arcade corresponding to the tumor is resected for a length of approximately 20 cm. For tumors close to the flexure, extended right/left hemicolectomy including removal of the neighbouring lymphatics, is necessary (14) .
CARCINOMAS OF THE LEFT FLEXURE
The standard procedure for tumors involving the left colonic flexure is extended left hemicolectomy with removal of the draining lymphatics serving the middle colic artery and the inferior mesenteric artery. An equally good alternative is the ligation of the left colic artery, with preservation of the trunk of the inferior mesenteric artery; in addition, the lymph nodes along the trunk of the inferior mesenteric artery can be dissected, while preserving the superior hypogastric plexus. In this way, the superior rectal artery is preserved, thus allowing the distal sigmoid to be preserverd. In the case of tumors of the left flexure and descending colon, para-aortic lymph node metastases may be found on the left right up to the left renal vein.
Continuity is re-established with ascendosigmoidostomy or ascendorectostomy, after prior mobilization of the right colon together with the entire mesenteric root as far as the duodenum, the colon is rotated anticlockwise and the appendix removed.
CARCINOMAS OF THE DESCENDING COLON
Carcinomas in the descending colon require a left hemicolectomy with radicular ligation of the inferior mesenteric artery. The distal limit of the resection of the bowel is in the upper third of the rectum. The left flexure is resected, and a transversorectostomy performed. If it is not possible to achieve a tensionfree anastomosis, the middle colic artery is transected and, if necessary, the resection extended up to the right flexure.
CARCINOMAS IN THE SIGMOID
Such tumors require resection of the sigmoid colon. The inferior mesenteric artery is ligated centrally or distal to the point of origin of the left colic artery. An oncological benefit associated with the high ligation of the inferior mesenteric artery has not been demonstrated. As a rule, the inferior mesenteric vein is divided at the lower border of the pancreas. The resection planes in the bowel are in the descending colon proximally, and the upper third of the rectum in the descending colon.
SPECIAL APPROACHES AND SITUATIONS
SYNCHRONOUS MULTIPLE CARCINOMAS 5.1 % (121/2365) of patients with carcinoma of the colon have a synchronous second tumor or multiple tumors in the large bowel (ERCRC). The incidence of synchronous adenoma in the colon and rectum varies between 35 and 50 % (15) . A clustered association with synchronous or metachronous second tumors of other tumor entities is to be found only in the hereditary forms of cancer of the colon.
In the case of multiple carcinomas of the colon, the extent of the resection is oriented to their lymphatic drainage. The result may be a subtotal colectomy or ascendorectostomy, or even colectomy with an ileorectostomy. In the case of a synchronous rectal carcinoma, the intervention must be extended analogously to the procedure for rectal carcinoma.
CARCINOMAS EXTENDING BEYOND ORGAN BOUNDARIES
In our own patient population, owing to macroscopic involvement of adjacent organs in the tumorous process, an extended resection became necessary in 177 out of 1477 (12.0 %) patients with no distant metastases. In 94 of these 177 cases (53.1 %) histology confirmed true tumor infiltration.
In addition to the demands made on dissection of the relevant draining lymphatics, such cases always necessitate en bloc resection of all the structures involved. Although in some one-half of the cases no histological evidence of infiltration is forthcoming, prior separation of the structures with the aim of checking for actual infiltration must not be done, since this would considerably increase the risk of peritoneal seeding and locoregional recurrence, even when merely inflammation-induced adhesions are present. The organs most frequently involved are the bladder, uterus and adnexa, together with parts of the abdominal wall and small bowel (Table 4) .
Such multivisceral resections with appropriate dissection technique can now be performed with a mortality rate of 2 %. If an R0 resection is possible, the cancer-specific survival is independent of whether there really has been tumor invasion into the adjacent structures (5-year survival rate 80.9 % vs. 82.9 %); rather it depends largely on the pN category (pN0 94.7 %, pN1 71.0 %, pN2 41.7 %) and on whether the integrity of the tumor has been compromised by tearing or cutting (82.5 % vs. 71.4 %, respectively; ERCRC). In our own experience, even patients with extensive infiltration of both the head of the pancreas and the liver by tumors of the right flexure have, after appropriate en bloc resection with inclusion of the pancreatic head and duodenum (Whipple's procedure) as well as several segments of the liver, have survived, recurrence-free for more than 10 years.
In the purely palliative situation, the risks of a surgical intervention extending beyond the standard procedure predominate in particular in the combination with resection of the pancreas, where the postoperative mortality rate is more than doubled. In general, multivisceral resection is of no benefit in such a situation. EMERGENCY PROCEDURES Some 10 % of all operations for colonic cancer are performed as emergency or urgent procedures (211/ 2019; Op. within 48 hours = 10.5 %; ERCRC). Such a situation usually indicates a more advanced carcinoma -for example, the incidence of synchronous distant metastases is 27 % as compared with 15 % for elective surgery. At 60-75 %, ileus is the most common underlying cause of the emergency. In 7.1 % (15 out of 2111) of our own patients, however, we merely constructed a stoma, but did not resect the primary tumor. In a further 3.3 % of the patients with a right-sided carcinoma we carried out only a bypass procedure.
Severe bleeding requiring emergency surgery is rarely seen (6 % of all emergency operations) in colon carcinoma.
In the majority of cases, including emergencies, our policy is to attempt a definitive operation, the extent of which complies with the recommendations of the oncological guidelines (in 75.5 % a single-stage, in a further 17.1 %, a two-stage procedure; ERCRC 1978-2001).
PREVENTIVE INTERVENTIONS
HNPCC
In contrast to familial adenomatous polyposis (FAP), no phenotypic markers are available for the diagnosis of hereditary non-polyposis colorectal cancer (HNPCC), so that family history data such as familial clustering and young age of onset of the condition continue to be applied (Amsterdam criteria, Bethesda criteria). If a carcinoma patient meets these criteria, the probability of mutation of one of the mismatch genes is high. In such a case, the moleculargenetic diagnostic work-up then enables unequivocal identification -which, however, usually takes several weeks after the operation.
Currently, therefore, curative resection with re-gional lymph node dissection is performed as in the case of a sporadic carcinoma. Admittedly, however, it must be expected that in patients with HNPCC, a conventional resection will be followed within the next 10 years by a second tumor in some 50 % of cases. This has prompted American surgeons in particular to advocate colectomy and ileorectal anastomosis for colonic carcinoma -which is considerably more frequent than rectal carcinoma with 70 % of the tumors located proximal to the left flexure -in HNPCC patients (16) . A rectal carcinoma would require a proctocolectomy, possibly with construction of a small bowel pouch. The good chance of early detection via regular colonoscopic screening is used as an argument against extended or prophylactic resection. Furthermore, HNPCC-associated carcinomas have a clearly better prognosis (observed 5-year survival rates approximately 85 % for HNPCC in comparison with 60 % for sporadic carcinoma), and the functional impact of extensive surgery must not be underestimated. A different situation from the above is pre-symptomatic DNA analysis in potential bearers of genetic mutations within the framework of family screening of affected 'index' patients. These patients have an approximately 79 % risk of developing colorectal carcinoma by the age of 80 (17) . A mandatory first step is always genetic counselling. The measures aimed at early detection of a tumor should include annual colonoscopic examinations beginning at the age of 25. In addition, yearly gynaecological and urological examinations and gastroscopy to exclude other organic manifestations are to be recommended (18) . If -in those with a relevant predisposition -a colorectal carcinoma is found, subtotal colectomy or proctocolectomy and ileorectostomy or an ileal pouch and pouchanal anastomosis is justified.
THE ROLE OF SURGERY WITHIN MULTIMODALITY TREATMENT CONCEPTS
Multimodality treatment concepts in the case of colonic cancer are currently limited mainly to adjuvant chemotherapy. Radiotherapy -as is established for rectal cancer -at the necessary irradiation dose is frequently not possible in the colon due to the proximity of radiosensitive small bowel and the more common problem of tumor obstruction. For patients with a stage I or II colonic carcinoma, there is presently no indication for adjuvant chemotherapy; phase III studies of stage II disease are presently being undertaken.
Several studies of the previous years confirmed the operating surgeon to be an independent prognostic factor in colon carcionoma. The fact that there are differences in the outcome quality with surgical treatment alone has been impressively demonstrated by the SGCRC, German Study Group for Colorectal Carcinoma. Here, in a total of 1157 consecutive colon cancer patients, the relative 5-year-survival was 60.2 %. However, among the seven participating centers, the survival figures ranged between 33 and 66 per cent. For R0-resections (n = 732), this range was even wider (46 % and 88 %) (19, 20) . As a com-parison, adjuvant treatment studies looking at stage III disease carried out over the past ten years have shown that recurrence-free survival can be prolonged by some 12 % in comparison with the corresponding surgical control arm (21) . These differences were markedly smaller in the studies by Dubé (5 %; 22) and Sargent (7 %; 23).
In the light of these data, especially of the German Study Group, there was some consideration whether such differences among individual hospital or surgeons may even appreciably exceed the improvements in the prognosis achievable by the use of adjuvant therapy. Namely, the high rate of local recurrence of nearly 20 % in the Moertel study raised doubts about the quality of the underlying surgical therapy. Possible reasons of the differences in survival rates in collectives under comparison could be caused by a varying volume of multivisceral resections, tumor cell dissemination and tumor incision or tear or by the extent of lymphatic dissection.
Subsequent studies were highlighting this problem by additional stringent quality assurance measures and documentation in surgery and pathology. These studies showed that even in optimal surgical therapy marked by a 3-year disease free survival of 61 %, thereby ranging 10 % above Moertel's study results, a further increase of 23 % (3-year disease free survival of 84 %) is possible by adjuvant chemotherapy as observed in the InTACT-study (24) . However, also in this study there are differences among the participating institutions (Table 5) . Table 5 : Inter-institutional differences persist even with adjuvant cheomotherapy for stage III colon cancer (24) . 
LOCOREGIONAL RECURRENCE
Locoregional recurrence after surgical treatment of colonic cancer is far less common than after surgery for rectal cancer. Nevertheless, its incidence is commonly underestimated.
In the SGCRC study, locoregional recurrences were observed in 10.5 % of all curative colonic cancer procedures. The hospital-related variation is considerable (4 %-24 %). Among our own patients, the 5-year local recurrence rate is 5 %. Here, locoregional recurrences in stage I and III disease play virtually no role; rather, they occur in the form of regional lymph node recurrence more frequently in stage III carcinomas, predominantly in the pN2 category (more than 3 lymph nodes involved).
DISTANT METASTASES
The presence of distant metastases has a major impact on the survival of patients with cancer of the colon. The probability of distant metastases depends largely on disease stage. However, such prognostic factors as malignancy grade, venous invasion, the surgeon and pre-operative serum CEA also have an Inter-institutional differences persist even with adjuvant cheomotherapy for stage III colon cancer (24) .
3-y.disease-free survival 80 %7 3 %7 3 %7 2 %6 7 %9 0 % impact on the risk for these metastases. Stage-related 5-year distant metastasis rates in the ERCRC patient material are shown in Table 6 , and are presented graphically in Figure 2 .
5. LONGTERM SURVIVAL
Cancer-related survival considers cancer as the cause of death, and is presented in Fig. 3 The leading prognostic factors in colorectal cancer are the anatomical spread of the tumor reflected in the pathological TNM classification, and residual tumor (R-) classification. In our patient material registered during the period 1988-1997, the cancer-related 5year survival rate following curative resection in stage I-IV disease was 82.9 % (n = 487), following noncurative resection, 4.8 % (n = 105). The prognosis of curative resection broken down by stage, is shown in Table 6 and Fig. 2 . Further factors accept- 
PERSPECTIVES
Surgical treatment of cancer of the colon has been standardized to a large extent. Nevertheless, a comparison among surgeons continues to reveal interindividual differences in outcome. Adjuvant therapies fail to eliminate such differences. This makes it clear that no compromises must be made in terms of the demand for optimal surgical technique.
In addition to the important endeavours to diagnose colorectal carcinoma at an earlier stage -since only in this way can a major advance in terms of a cure be expected -further efforts must concentrate on establishing even more differentiated and individualized multimodality treatment for more advanced carcinomas. In this endeavour, molecular and genetic markers will probably supplement the current TNM categories, which presently allow the best differentiation.
In parallel to this, disease staging, in particular intra-operatively, will permit surgical treatment to be further differentiated; here, again, the long-term outcome must not be left out of sight. This all the more so, since, in terms of quality of life, for example, a segmental resection of the right colon shows hardly any differences to classical right hemicolectomy. Procedures that are currently being tested in this regard are the molecular reflectance imaging technology based on fluorescent antibody dependent photooptic detection of microscopic tumor cell conglomerates (26) as well as modifications of the sentinel node / radionuclide detection techniques.
Despite all progress achieved in the surgery for colon cancer so far, one of the important challenges even of today are how to transfer optimal results of some surgeons to a broader basis, which means true implementation of the existing guidelines into surgical treatment of colorectal cancer.
